PharmaCyte Biotech (PMCB) Interest Coverage Ratio Growth (3y) (2013 - 2024)
PharmaCyte Biotech (PMCB) Interest Coverage Ratio Growth (3y) (2013 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 29.79% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 33.30% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 78.77% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 81.16% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -35.50% |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2024 | 96.25% |
| Jan 31, 2022 | -79.09% |
| Apr 30, 2020 | 11.53% |
| Apr 30, 2019 | 97.01% |
| Jan 31, 2019 | 86.49% |
| Apr 30, 2017 | -42.62% |
| Jan 31, 2017 | -278.11% |
| Oct 31, 2016 | -180.20% |
| Jul 31, 2016 | -137.49% |
| Jan 31, 2016 | -449.77% |
| Oct 31, 2015 | 802.73% |
| Jul 31, 2015 | -489.49% |
| Apr 30, 2015 | -574.51% |
| Jan 31, 2015 | -337.40% |
| Oct 31, 2014 | -529.45% |
| Jul 31, 2014 | -212.68% |
| Apr 30, 2014 | -947.70% |
| Jan 31, 2014 | -428.53% |
| Oct 31, 2013 | -459.14% |
| Jul 31, 2013 | -357.38% |